Squarepoint Ops »

Context Therapeutics shares owned by Squarepoint Ops

Quarter-by-quarter ownership of Context Therapeutics (CNTX) shares owned by Squarepoint Ops from 13F filings

Historical chart of Squarepoint Ops investment in Context Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Context Therapeutics held by Squarepoint Ops consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Context Therapeutics by Squarepoint Ops

Quarter filed Position value Share count Share price at filing
2026-06-30 $29k 53k 0.55

More positions owned by Squarepoint Ops

Ishares Tr Core S&p500 Etf (IVV)
State Str Spdr S&p 500 Etf T Tr Unit (SPY)
Invesco Qqq Tr Unit Ser 1 (QQQ)
NVIDIA Corporation (NVDA)
Advanced Micro Devices (AMD)
Ishares Tr Russell 2000 Etf (IWM)
Micron Technology (MU)
Vaneck Etf Trust Semiconductr Etf Put Option (SMH)
Amazon (AMZN)
Microsoft Corporation (MSFT)
Apple (AAPL)
Applied Materials (AMAT)
Tesla Motors (TSLA)
Intel Corporation (INTC)
Ishares Tr 20 Yr Tr Bd Etf (TLT)

View all positions for Squarepoint Ops

Top funds holding Context Therapeutics

Nextech Invest
Deep Track Capital
Soleus Capital Management
BlackRock
Avidity Partners Management
Franklin Resources
Vanguard Capital Management
Octagon Capital Advisors
Blue Owl Capital Holdings
TCG Crossover Management
Geode Capital Management
MPM Oncology Impact Management
Renaissance Technologies
Acadian Asset Management
ADAR1 Capital Management

View all funds holding Context Therapeutics